Cancer Biology & Medicine Open Access Editor-in-Chief: Xishan Hao
Volume 23 Issue 4, April 2026
PP. 451-558
|
8 articles
EDITORIAL
Editorial | Open Access
Cancer nanomedicine for therapy: emerging strategies and expanding perspectives
Published: 16 April 2026
2026, 23(4): 451-452
Editorial | Open Access
Enhancing cancer immunotherapy through polymer-based antibody conjugation technologies
Published: 24 November 2025
2026, 23(4): 453-460
Editorial | Open Access
Tumor microenvironment-responsive polymeric nanoparticles for enhanced immunotherapy
Published: 03 December 2025
2026, 23(4): 461-469
REVIEW
Review | Open Access
Postbiotics: emerging bioactive agents in cancer therapy
Published: 19 February 2026
2026, 23(4): 470-479
Review | Open Access
Click chemistry-driven tumor theranostics: recent advances, challenges, and future perspectives
Published: 12 March 2026
2026, 23(4): 480-503
Review | Open Access
From diagnostic marker-to-therapeutic modality: emerging paradigms in tumor biomineralization
Published: 20 April 2026
2026, 23(4): 504-526
Review | Open Access
Poor prognosis outcome tumors, bacteria-infected tumors and nanodrugs: current evidence and hypotheses towards a paradigm change for treatment
Published: 15 April 2026
2026, 23(4): 527-540
Review | Open Access
Design principles of nanomaterials for cancer immunotherapy: a mechanistic framework across the cancer immunity cycle
Published: 25 April 2026
2026, 23(4): 541-558